Screenshot of the web site of the Research Topic "Mechanistic, Machine Learning and Hybrid Models of the 'Other' Endocrine Regulatory Systems in Health and Disease: Volume II" in Frontiers in Systems Endocrinology
Are you researching #endocrine #feedback control systems?
Our Research Topic "Mechanistic, Machine Learning and Hybrid Models of the 'Other' Endocrine Regulatory Systems in Health and Disease: Volume II" is still open for submission.
www.frontiersin.org/research-top...
#endocrinology #cybernetics
07.09.2025 18:57 β π 20 π 10 π¬ 2 π 0
#SimulaBeta and #SimThyr provide the theoretical foundations for this revolutionary approach.
19.07.2025 14:18 β π 4 π 1 π¬ 1 π 0
Screenshot of SPINA Carb 5.1.0 Cycline on macOS 15.5 Sequoia, showing two Windows (entry and results).
SPINA Carb 5.1.0 Cyclone has been released in its final version.
#SPINA-GBeta #SPINA-GR #SPINA-DI #SPINA_Carb #insulin #glucose #homeostasis #prediabetes #diabetes
sourceforge.net/projects/spi...
doi.org/10.5281/zeno...
doi.org/10.5281/zeno...
13.07.2025 20:08 β π 6 π 3 π¬ 3 π 0
Screenshot of release candidate 3 of SPINA Carb 5.1 Cyclone on mac OS 15.5 Sequoia
Release candidate 3 for the software SPINA Carb Cyclone is available for macOS, Windows and Linux.
sourceforge.net/projects/spi...
doi.org/10.5281/zeno...
doi.org/10.5281/zeno...
#SPINA_Carb #SPINA-GBeta #SPINA-GR #SPINA-DI #HOMA
21.06.2025 14:26 β π 7 π 2 π¬ 1 π 1
Screenshot of SPINA Carb 5.1.0 (Cyclone) RC2 on macOS Ventura 13.7.5.
Release candidate 2 of #SPINA_Carb is available for testing.
sourceforge.net/projects/spi...
doi.org/10.5281/zeno...
doi.org/10.5281/zeno...
18.05.2025 09:19 β π 7 π 3 π¬ 0 π 0
Screenshot of SPINA Carb Release Candidate 1 for macOS
After intensive internal testing, the release candidate 1 of the #SPINA_Carb app is available. This is the "sister" app for #SPINA_Thyr, and it is provided for purposes of testing.
sourceforge.net/projects/spi...
doi.org/10.5281/zeno...
doi.org/10.5281/zeno...
21.04.2025 11:09 β π 6 π 2 π¬ 1 π 1
Table showing endotypes of insulin-glucose homeostasis in patients with hidradenitis suppurative (HS or acne inversa) and different expressions of haptoglobin concentration. In persons with HS and a high haptoglobin concentration, insulin sensitivity (SPINA-GR) and beta-cell function (SPINA-GBeta) are similar but combine to provide a reduced disposition index (SPINA-DI).
Plot of SPINA-GBeta versus SPINA-GR in patients with HS and controls: The majority of patients with HS and diabetes are faced with rather low insulin sensitivity and a lack of dynamic compensation via pancreatic beta-cell function, resulting in a reduced disposition index.
#Hidradenitis suppurativa (acne inversa) is linked to #diabetes mellitus. In the affected, #SPINA-GR is reduced and not compensated by #SPINA-GBeta, resulting in low #SPINA-DI. This phenomenon may be mediated by #inflammation, as shown by ties to #haptoglobin.
pubmed.ncbi.nlm.nih.gov/40217596/
13.04.2025 15:26 β π 18 π 2 π¬ 2 π 0
Graphical Abstract:
This novel fasting-based disposition index (SPINA-DI) is defined as the product of insulin receptor gain (SPINA-GR) multiplied by beta-cell function (SPINA-GBeta). SPINA-DI may be reduced due to insulin resistance with insufficient dynamical compensation of beta-cell mass (red horizontal arrow) or due to primary beta-cell failure (red vertical arrow).
SPINA-DI was validated in three cohorts. It had advantages in validity, reliability and diagnostic power compared to established criteria.
Sample title page of the Journal of Diabetes
I am honoured to see our paper "A novel simple disposition index (SPINA-DI) from fasting insulin and glucose concentration as a robust measure of carbohydrate homeostasis" among the "most impactful papers" of the #Journal_of_Diabetes.
onlinelibrary.wiley.com/doi/toc/10.1...
doi.org/10.1111/1753...
21.01.2025 18:16 β π 19 π 5 π¬ 1 π 0
Teilnehmer:innen gesucht!
Klinische Studie zur Verbesserung der Insulintherapie bei Typ 1-Diabetes
Sind Sie eine Person mit Typ 1 Diabetes und interessiert daran, die Auswirkungen von verschiedenen InsulinprΓ€paraten auf Ihren Blutzucker nach den Mahlzeiten zu erforschen? Haben Sie eventuell sogar Probleme mit Blutzuckerschwankungen nach der Mahlzeit? Wenn ja, kΓΆnnten Sie der SchlΓΌssel zu einer Personalisierung der Insulintherapie bei Menschen mit Typ 1 Diabetes sein.
Sprechen Sie uns an!
Kontaktieren Sie uns unter: insulinstudie@klinikum-bochum.de oder 0234-509-57813
Teilnehmer:innen gesucht! Klinische Studie zur Verbesserung der #Insulintherapie bei #Diabetes mellitus Typ 1.
www.klinikum-bochum.de/fachbereiche...
08.01.2025 23:06 β π 5 π 4 π¬ 0 π 0
In an unselected population sample (NHANES 2009/2010), persons with low thyroid's secretory capacity (SPINA-GT) and total step-up deiodinase activity (SPINA-GD) face significantly worse survival over 10 years.
In an unselected population sample (NHANES 2009/2010), persons with low beta-cell function (SPINA-GBeta) and static disposition index (SPINA-DI) are faced with significantly shorter survival over 10 years.
The method of structure parameter inference approach, i.e. #SPINA-Thyr and #SPINA_Carb, has predictive power in the setting of #P4_medicine. In a large population sample, four SPINA parameters, #SPINA-GT, #SPINA-GD, #SPINA-GBeta and #SPINA-DI, predicted all-cause mortality.
doi.org/10.53201/LEI...
28.12.2024 18:53 β π 6 π 3 π¬ 1 π 0
Graphical abstract: The novel fasting-based disposition index (SPINA-DI) is defined as the product of insulin receptor gain (SPINA-GR) multiplied by beta-cell function (SPINA-GBeta). SPINA-DI may be reduced due to insulin resistance with insufficient dynamical compensation of beta-cell mass (red horizontal arrow) or primary beta-cell failure (red vertical arrow).
SPINA-DI was validated in three cohorts. It had advantages in validity, reliability and diagnostic power compared to established criteria.
The disposition index of #insulin-glucose #homeostasis is an estimate for its loop gain. Its determination used to be complex, requiring clamp, IVGTT or OGTT experiments. We have developed a fasting-based method that is simpler and better π§ͺπ©Ί
pubmed.ncbi.nlm.nih.gov/38169110/
doi.org/10.1111/1753...
08.12.2024 22:45 β π 11 π 4 π¬ 1 π 0
Simulation speed with implementations in different programming languages. Shown is the time needed to simulate a first-order linear feedback loop (A) and a zeroth-order MiMe-NoCoDI loop (B) dependent on the number of iterations (proportional to simulated time, abscissa) based on implementations of the simulation program and the CyberUnits Bricks library in S, Python, Swift, C++ and Object Pascal. The ordinate is logarithmically scaled and represents the mean of 10 replications of each number of iteration steps.
Which programming language is fit for high-performance computer simulations in biomedical #cybernetics? We found that #Free_Pascal generates faster code than S/R and #Python. Interestingly, Object #Pascal even outperforms #Swift and C++. π§ͺπ©Ί
doi.org/10.14201/adc...
revistas.usal.es/cinco/index....
31.08.2024 09:31 β π 27 π 12 π¬ 6 π 1
Urkunde ΓΌber den Heinz von Foerster-Preis der Deutschen Gesellschaft fΓΌr Kybernetik, Informations- und Systemtheorie e. V. an Johannes W. Dietrich
Die Deutsche Gesellschaft fΓΌr #Kybernetik, Informations- und #Systemtheorie hat Peter K. Fleissner und mir den Heinz von Foerster-Preis verliehen.
Ich danke meinen Lehrer:innen und Kooperationspartner:innen, die meine Arbeit im Laufe der letzten 30 Jahre mΓΆglich gemacht haben.
11.04.2024 17:54 β π 9 π 2 π¬ 0 π 0
Gratulation an @drjwdietrich.bsky.social fΓΌr den Heinz-von-Foerster Preis fΓΌr Organisationskybernetik!
11.04.2024 11:35 β π 6 π 2 π¬ 0 π 1
Simple and Reliable Early Prediction of Diabetes
A simple blood test could perform better than a complex test thanks to mathematical modeling.
A novel method for early detection and #endotyping of #Diabetes mellitus relies on software written in #ObjectPascal.
Today, this innovative approach is covered by all major press agencies and news channels all over the globe.
news.rub.de/english/pres...
19.01.2024 12:37 β π 6 π 4 π¬ 1 π 0
4 Plots showing the hyperbolic relation between SPINA-GBeta (a measure for beta cell function) and SPINA-GR (reconstructed insulin receptor gain as a measure for insulin sensitivity).
(A) SPINA-DI remains constant as long as changes in insulin sensitivity (as measured by SPINA-GR) are balanced by adequate variations in beta cell function (SPINA-GBeta, circles 1, 2, and 3). (B) If dynamic compensation fails, either due to insufficient adaptation to insulin resistance (circle 4) or primary beta cell failure (circle 5), the disposition index breaks down and is markedly reduced. (C) Computer simulations with systematic variations of insulin receptor gain (GR) and secretory capacity of beta cells (GBeta) and resulting blood glucose concentration. (D) SPINA-GBeta plotted against SPINA-GR in the definition dataset. Results of persons with normal glucose homeostasis are near the hyperbola of normal SPINA-DI. The ability of dynamical beta cell compensation is partly lost in prediabetes.
Recently, computer simulations with #SimulaBeta played a key role in the development of the fasting-based disposition index SPINA-DI, a substantially improved method to assess the function of the insulin-glucose feedback loop and for early diagnosis of diabetes mellitus. π©Ί doi.org/10.1111/1753...
03.01.2024 22:26 β π 6 π 2 π¬ 1 π 1
Screenshot of SimulaBeta 3.1.2 on macOS Ventura 13.4.1
#SimulaBeta 3.1.2 is available. This service release fixes several bugs and is the first version to be based on #CyberUnits Bricks 2.0.
simulabeta.sourceforge.io
doi.org/10.5281/zeno...
doi.org/10.5281/zeno...
03.01.2024 19:10 β π 7 π 1 π¬ 0 π 0
Podcast host and science communicator. Author of the book, Beyond Banting. Supporting researchers and research organizations to communicate in ways that are understandable, empathetic and non-stigmatizing.π¨π¦ https://www.kristalamb.com
A clinician scientist at LTRI @sinaihealth studying Glucagon, GIP, GLP-1, GLP-2, diabetes, obesity, metabolism and the gut endocrine system
Scientist / diabetes researcher at BC Children's Hospital and UBC; Director, Centre for Molecular Medicine and Therapeutics; Co-founder, Integrated Nanotherapeutics. Interested in islets, mentorship, wine, baseball (Mariners), golf, theatre...
Senior Scientist BC Cancer | Senior Scientist @UHN | Associate Professor @UofT Immunology | Canada Research Chair in Tissue-Specific Immune Tolerance | NK cells, ILCs, T cells, immune regulation, human immunology | When Iβm not in the lab, Iβm on the water
Diabetes Researcher, Canadian, mother of dragons
Associate Professor @ CarletonU, she/her, islet biologist, mama bear, avid reader, nature-lover
Dad | #T1D my pancreas is on my phone | Assistant Professor of #NutSky and Chronic Disease | Newfoundlander in Winnipeg | Deutscher | Clinical Trialist | ADHD | he/him | Old man playing Rocket League | views my own
Canada's largest stand-alone research facility dedicated to translating discovery science into health solutions for the prevention, treatment and cure of diabetes. Home to leading researchers that produce an integrated & collaborative research environment.
Diabetes Reseach Envisioned and Accomplished in Manitoba (DREAM)
A translational research team aimed at improving the world of families & children living with diabetes.
www.dreamdiabetesresearch.com
contact: dream@chrim.ca
MD PhD Assistant Professor at University of Toronto, Scientist at ICES, Endocrinologist at University Health Network, Director @earlydiabetes.bsky.social. I research #diabetes & #globalhealth π
My lab studies sex differences in metabolism and metabolic disease in flies and mice. #sexdifferences #Drosophila #lipid #insulin #betacell
PhD candidate
Diabetes, nutrition, metabolism
University of Ottawa Heart Insitute
scientist. regeneration. mitochondria. diabetes. cancer. views my own.
Assistant Professor at IRCM, University of MontrΓ©al; Adjunct at McGill University. Stem cells, islets & regenerative medicine for T1D. AghazadehLab.com
She/her. TiohtiΓ‘:ke/Montreal. Opinions are my own.
Diabetes researcher at the University of British Columbia
π¨π¦ Helping people benefit from #deprescribing + evidence-based care in #learninghealthsystems | Co-Director, @deprescribing.bsky.social | Associate Prof, UofT | Pharmacist | @pharmacist_lisa from X/Twitter | #Pharmsky #SkyRx
ex-Torontonian, ex-Vancouverite, a Montrealer. Associate Prof. Canada Research Chair in Adipocyte Development. #EDI advocate
Associate Professor, University of Prince Edward Island
Heart and Stroke Foundation Canada Provincial Advisory Board for PEI